Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New combo therapy shows promise for kids with stubborn arthritis

NCT ID NCT07428551

First seen Mar 11, 2026 · Last updated May 22, 2026 · Updated 11 times

Summary

This study tested whether adding leflunomide to the standard drug methotrexate helps children with severe, hard-to-treat arthritis. Fifty children were split into two groups: one received both drugs, the other only methotrexate. Researchers tracked joint pain, swelling, and daily function over 24 weeks to see if the combination worked better.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for JUVENILE IDIOPATHIC ARTHRITIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Bangladesh Medical University

    Dhaka, Bangladesh

Conditions

Explore the condition pages connected to this study.